Attorney Michael Lin Baum is a managing partner at Baum Hedlund Aristei & Goldman, a law firm based in Los Angeles, California. A lawyer for over three decades, Michael Lin Baum represents clients injured by pharmaceutical drugs, including mothers on antidepressants who delivered babies with persistent pulmonary hypertension of the newborn (PPHN).
PPHN is a disorder where a newborn’s arteries to the lungs are constricted after birth, constraining blood flow to them and oxygen supply to the body. Babies with PPHN suffer severe respiratory failure and, sadly, 10-20 percent of them do not survive. The first link between antidepressants containing selective serotonin reuptake inhibitors (SSRI) and PPHN was made in 1996 by Dr. Christina Chambers. The doctor observed that women who took SSRIs in the late stages of their pregnancies raised the risk of their babies developing PPHN by up to six times higher.
Pregnant mothers have a right to know what risks SSRIs pose to their unborn babies so that they make the right choice for their families.
We just sent you an email. Please click the link in the email to confirm your subscription!
OKSubscriptions powered by Strikingly